Corinne Johnson

Stock Analyst at Goldman Sachs

(0.89)
# 2383
Out of 5,441 analysts
12
Total ratings
Success rate
Average return
7 Stocks
Name Action PT Current % Upside Ratings Updated
RNA Avidity Biosciences
Reinstates: Buy
55
45.74 20.24% 2 Jul 10, 2025
AVBP ArriVent BioPharma
Reinstates: Buy
33
17.4 89.66% 3 Jul 10, 2025
AMLX Amylyx Pharmaceutica...
Reinstates: Buy
10
7.81 28.04% 1 Jul 10, 2025
SNDX Syndax Pharmaceutica...
Initiates Coverage On: Buy
18
12.5 44% 1 Jul 10, 2025
NBIX Neurocrine Bioscienc...
Initiates Coverage On: Buy
182
123.99 46.79% 1 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
43 50
23.91 109.12% 3 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
50
14.76 238.75% 1 Mar 13, 2024